The SURMOUNT-1 trial for tirzepatide painted a similar picture, with roughly 25% of total weight lost coming from lean tissue and 75% from fat over the 72-week study period
Research advances suggest this powerful pair will become increasingly vital in preventative health and age management protocols
Combining them in one vial lets researchers examine both pathways in a single experimental system
Do not exceed recommended serving
Potential Risks and Side Effects of GLP-1 Medications As with any medication, there are potential risks and side effects associated with GLP-1 medications, which may include: Gastrointestinal side effects : Some of the most common side effects of GLP-1 medications are gastrointestinal in nature, such as nausea, vomiting, diarrhea, and constipation
Both treatments are delivered via a once-weekly injection, typically self-administered at home after training